Baker Heart Research Institute, Australia
Post-infarct ventricular remodeling is limited by transgenic alpha1A -adrenergic activation
Published in Cardiovascular Business Week, November 7th, 2006
According to recent research from Australia, "Myocardial contractility is enhanced in transgenic (TG) mice with cardiac-restricted overexpression of the alpha1A -adrenergic receptors (alpha1A -AR). We tested the hypothesis that this enhanced inotropy protects against dysfunction and remodeling after myocardial infarction (MI)."
"We subjected alpha1A -TG and non-TG mice (NTG) to MI and determined changes in left ventricular (LV) function and diastolic dimension (LVDd) by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Cardiome Pharma
Cardiome announces filing of shelf registration statement
Researchers from report recent findings in healthcare- Aachen University Hospital, Aachen, Germany
Studies from the United Kingdom and Germany add new findings to cardiology body of knowledge - Aachen University of Technology, Germany
Researchers' data from Germany, the United Kingdom and Norway advance imaging research - Aarhus University, Denmark
Recent findings from Denmark, Italy and the United States illuminate research in diabetes - Aarhus University, Denmark
Reports on bipolar disorders epidemiology findings from Aarhus University provide new insights - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
